2 options
Influenza Antiviral Drugs and Patent Law Issues.
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service.
- Language:
- English
- Subjects (All):
- United States. Laws, etc. (Statutes of the United States).
- United States.
- Licenses.
- Negotiation.
- Physical Description:
- 1 online resource (18 pages, digital, PDF file)
- Place of Publication:
- [Place of publication not identified] : [publisher not identified], 2007.
- System Details:
- text file
- Summary:
- Identifies and analyzes aspects of patent law affecting the availability and affordability of avian influenza antiviral medications such as the vaccine Tamiflu, produced by Roche, Inc. Examines legal options for increasing Tamiflu drug production, including the use of compulsory licensing under the Agreement on Trade-Related Aspects of Intellectual Property Rights and U.S. Code, and through sublicensing agreements voluntarily negotiated by Roche, Inc., with third-parties of its choosing.
- Notes:
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
- CRS Report.
- Other Format:
- Microfiche version: Library of Congress. Congressional Research Service. Influenza Antiviral Drugs and Patent Law Issues
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.